# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-007584
Filing Date
2025-05-13
Accepted
2025-05-13 16:36:35
Documents
64
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | anvs-20250331x10q.htm iXBRL | 10-Q | 867279
2 | EX-31.1 | anvs-20250331xex31d1.htm | EX-31.1 | 12670
3 | EX-31.2 | anvs-20250331xex31d2.htm | EX-31.2 | 12724
4 | EX-32.1 | anvs-20250331xex32d1.htm | EX-32.1 | 7907
| Complete submission text file | 0001558370-25-007584.txt |  | 4841531

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | anvs-20250331.xsd | EX-101.SCH | 40617
6 | EX-101.CAL | anvs-20250331_cal.xml | EX-101.CAL | 31083
7 | EX-101.DEF | anvs-20250331_def.xml | EX-101.DEF | 136250
8 | EX-101.LAB | anvs-20250331_lab.xml | EX-101.LAB | 320733
9 | EX-101.PRE | anvs-20250331_pre.xml | EX-101.PRE | 243364
67 | EXTRACTED XBRL INSTANCE DOCUMENT | anvs-20250331x10q_htm.xml | XML | 767266

Mailing Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355 484-875-3192
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39202 | Film No.: 25940796
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)